AEON Biopharma Inc. stock is traded at $0.1407, with a volume of 543,570. It is down -8.04% in the last 24 hours and down -39.35% over the past month. AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.
Previous Close:
$0.153
Open:
$0.1524
24h Volume:
543,570
Relative Volume:
0.40
Market Cap:
$10.06M
Revenue:
-
Net Income/Loss:
-$60.11M
P/E Ratio:
-
EPS:
-$4.35
Net Cash Flow:
-$12.04M
1W Performance:
-22.61%
1M Performance:
-39.35%
6M Performance:
-80.50%
1Y Performance:
-84.45%
1-Day Range:
$0.1407$0.1631
1-Week Range:
$0.1407$0.1823
52-Week Range:
$0.1271$1.45
AEON Biopharma Inc. Stock (AEON) Company Profile
Name
AEON Biopharma Inc.Sector
HealthcareIndustry
BiotechnologyPhone
(949) 354-6499Address
5 Park Plaza, Suite 1750, Irvine, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS